Pharmaceutical Information For You !
Updates from Pharmainfo.net website
Thursday, August 5, 2010
U.S. Food and Drug Administration Approves New Labeling for ISENTRESS® (raltegravir) to Include 96-Week Efficacy a...
http://ping.fm/9Mjbn
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment